SBI Life Insuran Q1 FY27 Earnings Call — Analysis (NSE: SBILIFE)
SBI Life Insurance Q1FY27 profit rises 22% YoY to ₹720 Cr; VNB margin at 26.2% despite GST drag; management guides margin to move towards upper end of 26-28% band as one-off group contract normalises.
The take
Q1FY27 Profit After Tax ₹720 Cr ( +22% YoY ) . New guidance — FY27 individual rated premium growth 14-15% . New story: Balanced growth with margin focus .
Results
Individual Rated Premium grew 14% YoY to ₹3,970 Cr, Gross Written Premium up 20% to ₹21,290 Cr, PAT up 22% to ₹720 Cr; VoNB margin 26.2%.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Individual Rated Premium | ₹3,970 Cr | +14% | yoy · Q1FY27 |
| Gross Written Premium | ₹21,290 Cr | +20% | yoy · Q1FY27 |
| Profit After Tax | ₹720 Cr | +22% | yoy · Q1FY27 |
| Value of New Business | ₹1,410 Cr | +29% | yoy · Q1FY27 |
| VoNB Margin | 26.2% | point_in_time · Q1FY27 · for Q1FY27; guidance range 26-28% | |
| Indian Embedded Value | ₹85,290 Cr | +15% | yoy · Q1FY27 · as on 30th June 2026 |
| Assets Under Management | ₹5,20,000 Cr | +10% | yoy · Q1FY27 · as on 30th June 2026 |
| Solvency Ratio | 1.96 | point_in_time · Q1FY27 · regulatory minimum 1.50 |
Guidance
FY27 Individual Rated Premium growth guided at 14-15%; VNB margin guided 26-28% and expected to trend towards the upper end as product mix normalises and GST impact fades after Q2.
What management committed to
- [SBI Life] expects Individual Rated Premium growth of 14-15% for FY27. — 14-15%, FY27
- [SBI Life] guides VNB margin in the 26-28% range for FY27. — 26-28%, FY27
- VoNB margin will trend towards the upper end of the 26-28% guidance band as product mix normalises after Q1FY27. — upper end of 26-28%, FY27
- [SBI Life's] agency channel will contribute an even stronger number in the remaining three quarters of FY27 compared to Q1FY27. — even a stronger number, FY27
- [SBI Life's] 61st month persistency will return to normal levels by the end of FY27. — back to normal, FY27
- Credit protect business will see a good uptick in the coming quarters. — some good uptick, FY27
- A regular pay deferred annuity product will be launched in the next quarter (Q2FY27). — Q2FY27
- The corporate agency tie-up with J&K Bank will start generating business in Q2FY27. — Q2FY27
- GST impact on VNB margin will persist for approximately 2.5 months in Q2FY27 and then fully cease. — some impact for 2.5 months then par-to-par, Q2FY27
- [SBI Life's] full-year FY27 product mix on IRP basis will be approximately 62% ULIP and 38% non-ULIP. — 62% ULIP, 38% non-ULIP, FY27
Key themes
Product mix diversification and margin recovery
How the narrative shifted
- Balanced growth with margin focus: Management emphasises steady IRP growth (14-15%) while holding VNB margin within the 26-28% band, signalling a disciplined approach to profitable expansion.
- Product mix shift to non-ULIP and protection: ULIP share declined from 65% to 61% on IRP basis; non-par savings and pure protection growing faster, driven by strategic product rebalancing and rider attachment.
- Agency channel expansion: Agency delivered 20% individual APE growth and is expected to strengthen further; branch and agent additions signal long-term commitment to diversify away from SBI bancassurance.
- One-off group protection contract masking underlying margin strength: A large GTI contract inflated group protection APE and temporarily depressed overall VNB margin; management frames it as non-recurring and not altering the margin trajectory.
- GST impact transitory: GST continues to be a margin headwind but will fade after Q2FY27 as the base effect laps; management expects no long-term structural drag.
- Persistency normalisation post-COVID cohort: 61st month persistency dipped due to the COVID cohort, a temporary effect that will reverse by year-end; other persistency buckets improved.
Operational commentary
- Agency channel individual APE up 20% YoY to ₹1,310 Cr, agent productivity ₹2 lakh; added ~34,000 agents and 11 branches; non-ULIP mix improved 300 bps.
- SBI bancassurance individual APE up 10% YoY to ₹2,450 Cr; branch productivity ₹4.1 Mn (+7% YoY); non-ULIP mix improved 200 bps.
- Other banks (non-SBI) individual NBP up 19% YoY; total other channels (direct, corp agents, brokers, online) grew 160% and now contribute 28% of total APE.
- Product mix shift: ULIP share on IRP basis down to 61% (vs 65% in Q1FY26); guaranteed non-par savings up 27% to ₹970 Cr; par APE up 35% to ₹240 Cr; individual protection APE up 18% with pure protection up 41%.
- Group protection APE surged 313% to ₹1,230 Cr, including a large one-year renewable GTI contract; this skewed total APE mix and temporarily dragged overall VNB margin.
- Rider attachment rate on ULIP and other products reached 45-50%, driving sum assured growth; 39% of individual sum assured now covered by riders.
- New corporate agency tie-up with J&K Bank signed; business expected to commence in Q2FY27.
- Persistency: 13th month 87.7% (+61 bps), 49th month 69.1% (+68 bps); 61st month dipped due to COVID cohort, expected to normalise by year-end.
- GST impact of ₹230 Cr; VoNB margin drag 1.1 pp; management expects GST impact to persist for 2.5 months in Q2FY27 and then cease.
- 99.9% individual proposals submitted digitally; 67% processed through automated underwriting.
- Regular pay deferred annuity product under development, launch targeted in Q2FY27.
Analyst Q&A
Q. Can you quantify the margin drag from the large GTI group protection contract and the positive offset in individual margins?
We don't generally discuss product-wise margins. We don't disclose those numbers.
Q. What assumption change drove the negative 40 bps in the VNB walk?
No new assumption change this quarter; the 40 bps is the base effect of the annual review changes made in March '26, which were negative 20 bps then.
Q. Why is individual protection APE growth only 18% when peers are reporting stronger numbers?
We are shifting mix from ROP to pure protection (up 41%), which has lower ticket size, so APE growth appears moderated but is as planned; pure protection growth is strong.
Research and educational content only. Not investment advice.